Scholar Rock Holding (STU:2QK) Change In Receivables : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Scholar Rock Holding Change In Receivables?

Scholar Rock Holding's change in receivables for the quarter that ended in Mar. 2025 was €0.00 Mil. It means Scholar Rock Holding's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Scholar Rock Holding's change in receivables for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means Scholar Rock Holding's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Scholar Rock Holding's Accounts Receivable for the quarter that ended in Mar. 2025 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Scholar Rock Holding's liquidation value for the three months ended in Mar. 2025 was €248.97 Mil.

Scholar Rock Holding Change In Receivables Historical Data

The historical data trend for Scholar Rock Holding's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scholar Rock Holding Change In Receivables Chart

Scholar Rock Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

20.55

Scholar Rock Holding Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Scholar Rock Holding Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Scholar Rock Holding (STU:2QK) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Scholar Rock Holding's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Scholar Rock Holding's accounts receivable are only considered to be worth 75% of book value:

Scholar Rock Holding's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	337.047	-	88.078	+	0.75 * 0	+	0.5 * 0
=	248.97

Scholar Rock Holding Change In Receivables Related Terms

Thank you for viewing the detailed overview of Scholar Rock Holding's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Scholar Rock Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SRRK:USA 2QK:Germany

Address

301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142

Website

https://www.scholarrock.com

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Scholar Rock Holding Headlines

No Headlines